drugset / Trial / NCT05046639

Sciatic Block in Contralateral Limb Phantom and Residual Limb Pain

NCT05046639 ↗

Phase 4 Terminated 1 enrolled Northwestern University
RandomizedCrossoverQuadruple-blindTreatment

Summary

Participants with chronic, refractory phantom limb pain (PLP) or residual limb pain (RLP) for more than 6 months will be enrolled in this clinical trial. Aim: Define the attributable pain relief and functional improvement in participants with PLP/RLP after contralateral limb sciatic nerve block. Also, contribute to the basic science understanding of the crossed-withdraw reflex by demonstrating a known animal model phenomenon in human participants. Hypothesis: Contralateral limb sciatic nerve anesthetic block with 2% lidocaine provides immediate clinically meaningful pain reduction, defined as the proportion of patients with at least 50% improvement in numeric rating scale (NRS) pain score in PLP/RLP when compared to sham.

Timeline

Start
2021-09-01
Primary completion
2023-07-26
Completion
2023-07-26

Outcome

Outcome not reported

Stopped: “Principal investigator is leaving the university.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 % Other
Subject Lidocaine Other / unclassified 10 ml Other

Indications

No indication recorded.